
CLDX Valuation
Celldex Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
CLDX Relative Valuation
CLDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLDX is overvalued; if below, it's undervalued.
Historical Valuation
Celldex Therapeutics Inc (CLDX) is now in the Fair zone, suggesting that its current forward PS ratio of 364.95 is considered Fairly compared with the five-year average of -13.65. The fair price of Celldex Therapeutics Inc (CLDX) is between 13.78 to 42.46 according to relative valuation methord.
Relative Value
Fair Zone
13.78-42.46
Current Price:22.36
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.11
P/B
Median3y
4.05
Median5y
4.29
-11.84
FCF Yield
Median3y
-7.13
Median5y
-6.27
Competitors Valuation Multiple
The average P/S ratio for CLDX's competitors is 72.65, providing a benchmark for relative valuation. Celldex Therapeutics Inc Corp (CLDX) exhibits a P/S ratio of 359.25, which is 394.47% above the industry average. Given its robust revenue growth of 345.51%, this premium appears sustainable.
People Also Watch

HE
Hawaiian Electric Industries Inc
10.860
USD
+0.37%

GLPG
Galapagos NV
33.290
USD
+1.56%

TDOC
Teladoc Health Inc
8.580
USD
+1.90%

VET
Vermilion Energy Inc.
8.210
USD
+1.61%

CSTM
Constellium SE
14.150
USD
-1.12%

MAG
MAG Silver Corp
21.790
USD
-1.63%

CUBI
Customers Bancorp Inc
62.550
USD
-1.14%

DMLP
Dorchester Minerals LP
27.420
USD
+1.11%

TVTX
Travere Therapeutics Inc
16.130
USD
+3.00%

TROX
Tronox Holdings PLC
5.850
USD
+4.46%
FAQ

Is Celldex Therapeutics Inc (CLDX) currently overvalued or undervalued?
Celldex Therapeutics Inc (CLDX) is now in the Fair zone, suggesting that its current forward PS ratio of 364.95 is considered Fairly compared with the five-year average of -13.65. The fair price of Celldex Therapeutics Inc (CLDX) is between 13.78 to 42.46 according to relative valuation methord.

What is Celldex Therapeutics Inc (CLDX) fair value?

How does CLDX's valuation metrics compare to the industry average?

What is the current P/B ratio for Celldex Therapeutics Inc (CLDX) as of Jul 24 2025?

What is the current FCF Yield for Celldex Therapeutics Inc (CLDX) as of Jul 24 2025?

What is the current Forward P/E ratio for Celldex Therapeutics Inc (CLDX) as of Jul 24 2025?
